Etherna
Belgium · $103.8M raised
- Business Model
- B2B
- Website
- etherna.be
- Total Funding
- $103.8M
- Last Round
- $39.0M Series BAug 2022
- Rounds
- 3
About
Etherna is a nucleic acid-based medicine technology platform company partnering with pharma and biotech on mRNA and LNP production.
Summary
Etherna is a Biotech company based in Belgium. It has raised $103.8M in total across 3 rounds, most recently a $39.0M Series B round in Aug 2022. Investors include Kenneth Chien / Novalis LifeSciences, PMV and Boehringer Ingelheim Venture Fund.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2022
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...